DE69940268D1 - Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung - Google Patents
Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendungInfo
- Publication number
- DE69940268D1 DE69940268D1 DE69940268T DE69940268T DE69940268D1 DE 69940268 D1 DE69940268 D1 DE 69940268D1 DE 69940268 T DE69940268 T DE 69940268T DE 69940268 T DE69940268 T DE 69940268T DE 69940268 D1 DE69940268 D1 DE 69940268D1
- Authority
- DE
- Germany
- Prior art keywords
- code
- dna fragments
- chlamydia
- chlamydia antigen
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000606161 Chlamydia Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 241001647372 Chlamydia pneumoniae Species 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- -1 DNA Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10659098P | 1998-11-02 | 1998-11-02 | |
| US13307199P | 1999-05-07 | 1999-05-07 | |
| US09/430,723 US6607730B1 (en) | 1998-11-02 | 1999-10-29 | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| PCT/GB1999/003622 WO2000026239A2 (en) | 1998-11-02 | 1999-11-02 | $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69940268D1 true DE69940268D1 (de) | 2009-02-26 |
Family
ID=27380151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69940268T Expired - Fee Related DE69940268D1 (de) | 1998-11-02 | 1999-11-02 | Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6607730B1 (de) |
| EP (1) | EP1127065B1 (de) |
| JP (1) | JP2002530054A (de) |
| AT (1) | ATE420106T1 (de) |
| AU (1) | AU753984B2 (de) |
| CA (1) | CA2349504A1 (de) |
| DE (1) | DE69940268D1 (de) |
| NZ (1) | NZ511889A (de) |
| WO (1) | WO2000026239A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000034498A1 (en) * | 1998-12-04 | 2000-06-15 | University Of Manitoba | Two-step immunization procedure against chlamydia infection |
| US20020061848A1 (en) * | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| JP2003507433A (ja) * | 1999-08-20 | 2003-02-25 | ザ ゼネラル ホスピタル コーポレーション | 敗血症治療において治療に用いる対象としての外膜タンパク質ａ、ペプチドグリカン関連リポタンパク質およびムレインリポタンパク質 |
| CA2395499C (en) * | 1999-12-22 | 2011-10-25 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| GB0103169D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010032336A (ko) | 1997-11-21 | 2001-04-16 | 브랑디 빠스깔 | 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
| KR100769103B1 (ko) | 1997-11-28 | 2007-10-23 | 세로노 제네틱스 인스티튜트 에스.에이. | 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
| JP2002529069A (ja) | 1998-11-12 | 2002-09-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | クラミジア・ニューモニエのゲノム配列 |
| US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| KR20100132086A (ko) | 1998-12-08 | 2010-12-16 | 코릭사 코포레이션 | 클라미디아 감염을 치료 및 진단하기 위한 조성물 및 이를 포함하는 약제학적 조성물 및 진단 키트 |
| US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| GB9902555D0 (en) | 1999-02-05 | 1999-03-24 | Neutec Pharma Plc | Medicament |
| DE60036698T2 (de) | 1999-05-03 | 2008-07-24 | Sanofi Pasteur Ltd., Toronto | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen |
| NZ517952A (en) | 1999-09-20 | 2004-01-30 | Aventis Pasteur | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
| CA2395499C (en) | 1999-12-22 | 2011-10-25 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| DE60133190T2 (de) | 2000-04-21 | 2009-04-02 | CORIXA CORP., Wilmington | Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen |
| WO2001085972A2 (en) | 2000-05-08 | 2001-11-15 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| CA2414884A1 (en) | 2000-07-03 | 2002-01-10 | Chiron S.P.A. | Immunisation against chlamydia pneumoniae |
-
1999
- 1999-10-29 US US09/430,723 patent/US6607730B1/en not_active Expired - Fee Related
- 1999-11-02 JP JP2000579626A patent/JP2002530054A/ja active Pending
- 1999-11-02 NZ NZ511889A patent/NZ511889A/en not_active IP Right Cessation
- 1999-11-02 AT AT99954126T patent/ATE420106T1/de not_active IP Right Cessation
- 1999-11-02 DE DE69940268T patent/DE69940268D1/de not_active Expired - Fee Related
- 1999-11-02 CA CA002349504A patent/CA2349504A1/en not_active Abandoned
- 1999-11-02 EP EP99954126A patent/EP1127065B1/de not_active Expired - Lifetime
- 1999-11-02 AU AU10565/00A patent/AU753984B2/en not_active Ceased
- 1999-11-02 WO PCT/GB1999/003622 patent/WO2000026239A2/en active IP Right Grant
-
2003
- 2003-01-28 US US10/352,618 patent/US20040022801A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU1056500A (en) | 2000-05-22 |
| EP1127065B1 (de) | 2009-01-07 |
| WO2000026239A2 (en) | 2000-05-11 |
| NZ511889A (en) | 2003-12-19 |
| ATE420106T1 (de) | 2009-01-15 |
| US6607730B1 (en) | 2003-08-19 |
| JP2002530054A (ja) | 2002-09-17 |
| EP1127065A2 (de) | 2001-08-29 |
| WO2000026239A3 (en) | 2000-08-10 |
| AU753984B2 (en) | 2002-10-31 |
| CA2349504A1 (en) | 2000-05-11 |
| US20040022801A1 (en) | 2004-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001046224A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2000066739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2002074979A3 (en) | Expression profiles and methods of use | |
| HUP0402271A2 (hu) | Pseudoplectania nigrellá-ból származó antimikrobiális polipeptidek | |
| WO2001070174A3 (en) | Vegf-modulated genes and methods employing them | |
| DE69634412D1 (de) | Regulierte gene und ihre verwendungen | |
| AR047347A1 (es) | Miembros de la familia cry9 de bacillus | |
| AR062019A1 (es) | Gen de bacillus thuringiensis con actividad contra lepidopteros | |
| RS92704A (en) | Immunoglobulin-domain containing cell surface recognition molecules | |
| DE60125350D1 (de) | Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen | |
| WO2002040668A3 (de) | Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen | |
| WO2001046225A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| DK0981631T3 (da) | Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme | |
| WO2001075111A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075113A3 (en) | Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof | |
| WO2001074863A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| DE60041042D1 (de) | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon | |
| WO2001075112A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075114A3 (en) | Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof | |
| DE69940268D1 (de) | Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung | |
| WO2001046226A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| MXPA01004353A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
| WO2000006742A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| MXPA01001639A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
| CA2628354A1 (en) | Organic cation transporter genes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |